1. Plasma concentration of gestodene and endogenous sexual hormones in a 21-day treatment cycle with the new oral contraceptive and in two further treatment cycles with defined 2-day breaks in treatment in 6 young women;Düsterberg;Arch Gynecol,1985
2. Single dose pharmacokinetics of gestodene after intravenous and oral administration in women;Täuber;Contraception,1989
3. Alterations in the serum levels of gestodene and SHBG during 12 cycles of treatment with 30 μg ethinylestradiol and 75 μg gestodene;Kuhl;Contraception,1988
4. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations;Kuhnz;Arzneim Forsch,1992
5. Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months;Dibbelt;Arzneim Forsch,1992